Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, January 2000, p. 196-199, Vol. 44, No. 1
0066-4804/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Sequence Analysis of ARI-1, a Novel OXA
-Lactamase, Responsible for Imipenem Resistance in
Acinetobacter baumannii 6B92
Helen M.
Donald,1
Wendy
Scaife,1
Sebastian G. B.
Amyes,2 and
Hilary-Kay
Young1,*
Department of Biological Sciences, University
of Dundee, Dundee DD1 4HN,1 and
Department of Medical Microbiology, University of Edinburgh
Medical School, Edinburgh EH8 9AG,2 United
Kingdom
Received 12 May 1999/Returned for modification 12 August
1999/Accepted 15 October 1999
 |
ABSTRACT |
The sequence of the blaARI-1 gene from
imipenem-resistant Acinetobacter baumannii 6B92 has been
determined. The structural gene encodes a 273-amino-acid protein which
is most related to the OXA class D
-lactamases. The conserved
S-T-F-K and K-T-G motifs were identified in the ARI-1 protein sequence,
also named OXA-23, but significantly, a point mutation (Y
F) was
identified in the Y-G-N conserved motif, also known to function in the
active site.
 |
TEXT |
Multiresistant Acinetobacter
baumannii strains are now recognized as serious nosocomial
pathogens (4, 5), and carbapenem-resistant strains are being
reported increasingly (1, 3, 6, 11, 15, 18, 23).
Imipenem-resistant A. baumannii 6B92 was isolated from a
patient in Edinburgh, United Kingdom, in 1985 (15). Imipenem resistance was attributed to a novel serine
-lactamase, ARI-1 (15), and was subsequently demonstrated to be transferable
to Acinetobacter junii (18). Imipenem resistance
due to
-lactamases in A. baumannii has subsequently been
reported worldwide, and two additional
-lactamases, ARI-2
(6) and an oxacillin-hydrolyzing enzyme (2, 11),
defined only by their biochemical properties, have been described. In
this paper we report the nucleotide and deduced amino acid sequences of
ARI-1 carried by the R plasmid pUK1356.
Bacterial strains and plasmids.
The transconjugant A. junii BD413-2(pUK1356) was used as the source of ARI-1.
Escherichia coli TG2 {supE hsd
5 thi
(lac-proAB)
(slr-recA)
306::Tn10(tetr)
F'[traD36 proAB+ lacIq
lacZ
M15]} (17) was used as a host for
recombinant plasmids prepared in the vector pUC19 (24).
-Lactamase purification and N-terminal amino acid
sequencing.
Cell extracts of A. junii BD413-2(pUK1356)
were loaded onto a Mono Q anion-exchange column (Pharmacia Co. Ltd.,
Uppsala, Sweden) equilibrated with 50 mM Tris-HCl (pH 8.2). Fractions
were eluted with a gradient of 0 to 0.5 M NaCl in 50 mM Tris-HCl (pH
8.2). The ARI-1
-lactamase, eluted in the unadsorbed fraction, was loaded onto a Superdex-75 gel filtration column (Pharmacia)
equilibrated in 50 mM Tris-HCl (pH 7.5) containing 0.1 M NaCl.
Fractions containing
-lactamase activity, detected by an assay with
nitrocefin (Glaxo Group Research Ltd., Greenford, United Kingdom), were
concentrated by centrifugation using VectaSpin microtube filters, with
a molecular mass cutoff of 12 kDa (Whatman International Ltd.,
Maidstone, United Kingdom). Following native PAGE, ARI-1 was
transferred to a Problot membrane (PE Applied Biosystems, Warrington,
United Kingdom), stained with Coomassie blue, and cut out for
N-terminal sequencing with a model 477A gas phase sequencer (PE Applied
Biosystems). The 20 N-terminal amino acids were used to prepare the
degenerate oligonucleotide probe ARI-N (Table 1).
Restriction enzymes and DNA cloning.
Restriction enzymes (Life
Technologies Ltd., Paisley, United Kingdom) were used in accordance
with the manufacturer's instructions. Plasmid pUK1356 was extracted,
restricted, and cloned with the procedures described by Sambrook et al.
(17). Recombinant clones were selected on nutrient agar (IDG
Ltd., Bury, United Kingdom) containing X-Gal
(5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside; 32.5 mg/liter), IPTG (isopropyl-
-D-thiogalactopyranoside; 7.8 mg/liter), and ampicillin (50 mg/liter; Sigma Aldrich Co. Ltd., Poole,
United Kingdom).
Hybridization and identification of the 5' end of the ARI-1
gene.
Enhanced chemiluminescence probe labelling, hybridization,
and detection kits (Amersham Pharmacia Biotech UK Ltd., Amersham, United Kingdom) were used in accordance with the manufacturer's instructions. A partial library of pUK1356 recombinant clones was
screened with an ARI-N probe 3' end labelled with fluorescein-dUTP. Recombinant plasmid from a single positive clone was purified with a
Qiagen (Crawley, United Kingdom) plasmid minikit and sequenced with an
ABI PRISM 377 automated DNA sequencer (PE Applied Biosystems). The
sequence (Fig. 1, nucleotides 1 to 1345) revealed 375 bp of the 5' end
of the blaARI-1 gene.
PCR amplification and complete sequencing of the ARI-1 gene.
PCRs were carried out in 100-µl volumes containing 16 mM
(NH4)2SO4, 67 mM Tris-HCl (pH 8.8),
0.1% Tween 20 buffer, 2.5 mM MgCl2, 0.2 mM deoxynucleoside
triphosphates (Amersham Pharmacia Biotech UK Ltd.), 0.1 to 0.5 µM
each primer, and 1 U of BIOTAQ polymerase (Bioline UK Ltd., London,
United Kingdom) or 1.25 U of Pfu DNA polymerase (Promega UK
Ltd., Southampton, United Kingdom). Template DNA was boiled for 10 min
before being added to the reaction mixture. DNA amplification was
performed in an Omn-E thermal cycler (Hybaid Ltd., Teddington, United
Kingdom) under the following cycle conditions: 94°C for 5 min, 60°C
for 1 min, 72°C for 2 min (one cycle); 94°C for 15 s, 60°C
for 1 min, 72°C for 2 min (30 cycles); and a final extension of
72°C for 5 min (one cycle). PCR products containing the 3' end of the
ARI-1 gene were obtained by inverse PCR of HincII or
Sau3A fragments of pUK1356 by using the primer pairs P1-P2
and Invrs2-Invrs3 (Table 1). PCR products comprising the complete sequence of the blaARI-1
gene were generated by using the primer pair P5-P6 (Table 1). The ARI-1
gene sequence was determined from both strands with PCR products from
three independent reactions, at least one of which was generated with Pfu DNA polymerase, being sequenced routinely.
Sequence data analysis, alignment, and phylogeny.
For computer
analysis of sequence data, the software from the BCM Search Launcher
was used (21). The blaARI-1 gene
comprises an 822-bp open reading frame, between the initiation codon
ATG (positions 972 to 974) and the stop codon TAA (positions 1791 to
1793), which translates into a protein of 273 amino acids (Fig. 1) showing sequence homology to Ambler
class D (Bush group 2d) oxacillin-hydrolyzing enzymes. Some unique
features and distinct biochemical properties were noted. Two highly
conserved motifs, S-T-F-K and K-T-G (positions 79 to 82 and 216 to
218), believed to contribute to the function of the serine active site
(7, 12), were identified (Fig. 1). A third motif, F-G-N at
positions 152 to 154, which differs from the corresponding motif in all other OXA enzymes by the presence of phenylalanine instead of tyrosine.
This unique substitution may have significant biochemical effects and
is possibly a factor in the evolution of carbapenem resistance in this
enzyme. A cladogram was constructed to relate ARI-1 to 18 other class D
-lactamases (Fig. 2). ARI-1 showed less than 40% identity with other OXA enzymes. Greatest identity was
observed with OXA-5 and OXA-10 (36% identity), 35% identity was
observed with OXA-7 and OXA-11, and 32% identity was observed with
LCR-1 (8). ARI-1 is therefore a novel class D
-lactamase and has been assigned the alternative name OXA-23.

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 1.
Nucleotide and deduced amino acid sequences of the ARI-1
gene and the ARI-1 protein from A. baumannii 6B92. The
boldface ATG and TAA represent the initiation and termination codons,
respectively. The -lactamase active site S-T-F-K and the conserved
motifs F-G-N and K-T-G are shown in boldface type. A proposed cleavage
site generating a possible signal sequence is indicated with a vertical
arrow. Nucleotide sequence in italics shows >90% homology with the
phaBAc upstream region (19). indicates the transcription start site identified by Schembri et al.
(20). An imperfect inverted repeat sequence at the 3' end of
the gene is shown by a broken line, and possible cassette junctions are
shown boxed.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Cladogram relating ARI-1 to 18 other class D
-lactamases. Analysis was done with the CLUSTAL W Multiple Sequence
Alignment Program (22), based on a progressive alignment
using the minimum mutation matrix of Dayhoff for scoring
(9). A gap penalty of 3 was applied, and 100 bootstrap
replications gave node values.
|
|
Analysis of the genetic environment of
blaARI-1.
The majority of oxa
genes are contained within mobile cassettes (13, 14, 16)
normally found inserted within integrons (10). The sequence
immediately upstream of the blaARI-1 structural gene did not reveal cassette characteristics (i.e., consensus core
sequence GTTRRRY). Nevertheless, a large region of 944 bases showing
more than 90% homology with the phaBAc upstream
region previously identified in the chromosome and plasmids of
Acinetobacter strains isolated from sludge (19)
was found. Schembri et al. (20) have shown a transcription
start point within this region (position 920 in Fig. 1). This may
indicate that the blaARI-1 gene has been
specifically inserted downstream of an active promoter, enabling
low-level constitutive expression of the gene in A. baumannii. Analysis of the region immediately downstream of
blaARI-1 revealed an imperfect inverted repeat
sequence with some of the characteristics of the 59-bp recombination
sites found in cassette structures (16). Although
characteristic of gene cassettes, it is possible that this sequence is
functioning as a transcription terminator sequence since there was no
evidence of an inverse core sequence (consensus sequence RYYYAAC).
Furthermore, continuation of the published pha operon
sequence could not be identified. Despite the apparent lack of evidence
of an integron or cassette location for the
blaARI-1 gene, two GTTA sequences (boxed in Fig.
1) were identified and may define the ends of a potential novel and
unusual cassette structure.
Nucleotide sequence accession number.
The nucleotide sequence
data reported in this paper will appear in the EMBL nucleotide database
under accession no. AJ132105.
 |
ACKNOWLEDGMENTS |
We thank Peter Rowell for assistance with the enzyme purification procedures.
This work was funded by the Scottish Office Home and Health Department
(grant no. K/MRS/50/C2522).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biological Sciences, University of Dundee, Dundee DD1 4HN, United
Kingdom. Phone: 44 (0)1382 344270. Fax: 44 (0)1382 344275. E-mail:
h.k.young{at}dundee.ac.uk.
 |
REFERENCES |
| 1.
|
Afzal-Shah, M., and D. M. Livermore.
1998.
Worldwide emergence of carbapenem-resistant Acinetobacter spp.
J. Antimicrob. Chemother.
41:576-577[Free Full Text].
|
| 2.
|
Afzal-Shah, M.,
H. E. Villar, and D. M. Livermore.
1999.
Biochemical characteristics of a carbapenemase from an Acinetobacter baumannii isolate collected in Buenos Aires, Argentina.
J. Antimicrob. Chemother.
43:127-131[Abstract/Free Full Text].
|
| 3.
|
Amyes, S. G. B.
1997.
-Lactam resistance and the use of inhibitor combinations.
J. Med. Microbiol.
46:728-731.
|
| 4.
|
Bauernfeind, A.,
S. Kljucar, and R. Jungwirth.
1997.
Overview of antibiotic resistance problems in Acinetobacter spp.
J. Med. Microbiol.
46:726-728.
|
| 5.
|
Bergogne-Berezin, E., and K. J. Towner.
1996.
Acinetobacter spp, as nosocomial pathogens: microbiological, clinical, and epidemiological features.
Clin. Microbiol. Rev.
9:148-165[Medline].
|
| 6.
|
Brown, S.,
C. Bantar,
H.-K. Young, and S. G. B. Amyes.
1998.
Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2.
Lancet
351:186-187[CrossRef][Medline].
|
| 7.
|
Bush, K.,
G. A. Jacoby, and A. A. Mederios.
1995.
A functional classification scheme for -lactamases and its correlation with molecular structure.
Antimicrob. Agents Chemother.
39:1211-1233[Medline].
|
| 8.
|
Couture, F.,
J. Lachapelle, and R. C. Levesque.
1992.
Phylogeny of LCR-1 and OXA-5 with class A and class D -lactamases.
Mol. Microbiol.
6:1693-1705[Medline].
|
| 9.
|
Dayhoff, M. O.,
R. M. Schwartz, and B. C. Orcutt.
1978.
A model of evolutionary change in proteins, p. 345-352.
In
M. O. Dayhoff (ed.), Atlas of protein sequence and structure, vol. 5, suppl. 5. National Biomedical Research Foundation, Georgetown University Medical Center, Washington, D.C.
|
| 10.
|
Hall, R. M., and C. M. Collis.
1995.
Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination.
Mol. Microbiol.
15:593-600[CrossRef][Medline].
|
| 11.
|
Hornstein, M.,
C. Sautjeau-Rostoker,
J. Peduzzi,
A. Vessieres,
L. T. H. Hong,
M. Barthelemy,
M. Scavizzi, and R. Labia.
1997.
Oxacillin-hydrolyzing -lactamase involved in resistance to imipenem in A. baumannii.
FEMS Microbiol. Lett.
153:333-339[Medline].
|
| 12.
|
Massova, I., and S. Mobashery.
1998.
Kinship and diversification of bacterial penicillin-binding proteins and -lactamases.
Antimicrob. Agents Chemother.
42:1-17[Free Full Text].
|
| 13.
|
Mugnier, P.,
I. Podglajen,
F. W. Goldstein, and E. Collatz.
1998.
Carbapenems as inhibitors of OXA-13, a novel integron-encoded -lactamase in Pseudomonas aeruginosa.
Microbiology
144:1021-1031[Abstract/Free Full Text].
|
| 14.
|
Naas, T.,
W. Sougakoff,
A. Casetta, and P. Nordmann.
1998.
Molecular characterization of OXA-20, a novel class D -lactamase, and its integron from Pseudomonas aeruginosa.
Antimicrob. Agents Chemother.
42:2074-2083[Abstract/Free Full Text].
|
| 15.
|
Paton, R.,
R. S. Miles,
J. Hood, and S. G. B. Amyes.
1993.
ARI-1: -lactamase-mediated imipenem resistance in Acinetobacter baumannii.
Int. J. Antimicrob. Agents
2:81-88.
|
| 16.
|
Recchia, G. D., and R. M. Hall.
1995.
Gene cassettes: a new class of mobile element.
Microbiology
141:3015-3027[Free Full Text].
|
| 17.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y
|
| 18.
|
Scaife, W.,
H.-K. Young,
R. Paton, and S. G. B. Amyes.
1995.
Transferable imipenem-resistance in Acinetobacter species from a clinical source.
J. Antimicrob. Chemother.
36:585-586[Free Full Text].
|
| 19.
|
Schembri, M. A.,
R. C. Bayly, and J. K. Davies.
1994.
Cloning and analysis of the polyhydroxyalkanoic acid synthase gene from Acinetobacter sp.: evidence that the gene is both plasmid and chromosomally located.
FEMS Microbiol. Lett.
118:145-152[CrossRef][Medline].
|
| 20.
|
Schembri, M. A.,
R. C. Bayly, and J. K. Davies.
1995.
Phosphate concentration regulates transcription of the Acinetobacter polyhydroxyalkanoic acid biosynthetic genes.
J. Bacteriol.
177:4501-4507[Abstract/Free Full Text].
|
| 21.
|
Smith, R. F.,
B. A. Wiese,
M. K. Wojzynski,
D. B. Davidson, and K. C. Worley.
1996.
BCM Search Launcher-an integrated interface to molecular biology data base search and analysis services available on the World Wide Web.
Genome Res.
6:454-462[Abstract/Free Full Text].
|
| 22.
|
Thompson, J. D.,
D. G. Higgens, and T. J. Gibson.
1994.
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
Nucleic Acids Res.
22:4673-4680[Abstract/Free Full Text].
|
| 23.
|
Weinbren, M. J.,
A. P. Johnson,
M. E. Kaufmann, and D. M. Livermore.
1998.
Acinetobacter spp. isolates with reduced susceptibilities to carbapenems in a UK burns unit.
J. Antimicrob. Chemother.
41:574-576[Free Full Text].
|
| 24.
|
Yanisch-Perron, C.,
J. Vieira, and J. Messing.
1985.
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.
Gene
33:103-119[CrossRef][Medline].
|
Antimicrobial Agents and Chemotherapy, January 2000, p. 196-199, Vol. 44, No. 1
0066-4804/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Mak, J. K., Kim, M.-J., Pham, J., Tapsall, J., White, P. A.
(2009). Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother
63: 47-54
[Abstract]
[Full Text]
-
Peleg, A. Y., Seifert, H., Paterson, D. L.
(2008). Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin. Microbiol. Rev.
21: 538-582
[Abstract]
[Full Text]
-
Chen, T.-L., Wu, R. C.-C., Shaio, M.-F., Fung, C.-P., Cho, W.-L.
(2008). Acquisition of a Plasmid-Borne blaOXA-58 Gene with an Upstream IS1008 Insertion Conferring a High Level of Carbapenem Resistance to Acinetobacter baumannii. Antimicrob. Agents Chemother.
52: 2573-2580
[Abstract]
[Full Text]
-
Poirel, L., Figueiredo, S., Cattoir, V., Carattoli, A., Nordmann, P.
(2008). Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter spp.. Antimicrob. Agents Chemother.
52: 1252-1256
[Abstract]
[Full Text]
-
Beceiro, A., Fernandez-Cuenca, F., Ribera, A., Martinez-Martinez, L., Pascual, A., Vila, J., Rodriguez-Bano, J., Cisneros, J. M., Pachon, J., Bou, G., on behalf of the Spanish Group for Nosocomial Infe,
(2008). False extended-spectrum {beta}-lactamase detection in Acinetobacter spp. due to intrinsic susceptibility to clavulanic acid. J Antimicrob Chemother
61: 301-308
[Abstract]
[Full Text]
-
Doi, Y., Adams, J. M., Yamane, K., Paterson, D. L.
(2007). Identification of 16S rRNA Methylase-Producing Acinetobacter baumannii Clinical Strains in North America. Antimicrob. Agents Chemother.
51: 4209-4210
[Abstract]
[Full Text]
-
Zhou, H., Pi, B.-R., Yang, Q., Yu, Y.-S., Chen, Y.-G., Li, L.-J., Zheng, S.-S.
(2007). Dissemination of imipenem-resistant Acinetobacter baumannii strains carrying the ISAba1 blaOXA-23 genes in a Chinese hospital. J Med Microbiol
56: 1076-1080
[Abstract]
[Full Text]
-
Queenan, A. M., Bush, K.
(2007). Carbapenemases: the Versatile {beta}-Lactamases. Clin. Microbiol. Rev.
20: 440-458
[Abstract]
[Full Text]
-
Corvec, S., Poirel, L., Naas, T., Drugeon, H., Nordmann, P.
(2007). Genetics and Expression of the Carbapenem-Hydrolyzing Oxacillinase Gene blaOXA-23 in Acinetobacter baumannii. Antimicrob. Agents Chemother.
51: 1530-1533
[Abstract]
[Full Text]
-
Santillana, E., Beceiro, A., Bou, G., Romero, A.
(2007). Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis. Proc. Natl. Acad. Sci. USA
104: 5354-5359
[Abstract]
[Full Text]
-
Valenzuela, J. K., Thomas, L., Partridge, S. R., van der Reijden, T., Dijkshoorn, L., Iredell, J.
(2007). Horizontal Gene Transfer in a Polyclonal Outbreak of Carbapenem-Resistant Acinetobacter baumannii. J. Clin. Microbiol.
45: 453-460
[Abstract]
[Full Text]
-
Hujer, K. M., Hujer, A. M., Hulten, E. A., Bajaksouzian, S., Adams, J. M., Donskey, C. J., Ecker, D. J., Massire, C., Eshoo, M. W., Sampath, R., Thomson, J. M., Rather, P. N., Craft, D. W., Fishbain, J. T., Ewell, A. J., Jacobs, M. R., Paterson, D. L., Bonomo, R. A.
(2006). Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center. Antimicrob. Agents Chemother.
50: 4114-4123
[Abstract]
[Full Text]
-
Boo, T. W., Walsh, F., Crowley, B.
(2006). First report of OXA-23 carbapenemase in clinical isolates of Acinetobacter species in the Irish Republic. J Antimicrob Chemother
58: 1101-1102
[Full Text]
-
Bogaerts, P., Naas, T., Wybo, I., Bauraing, C., Soetens, O., Pierard, D., Nordmann, P., Glupczynski, Y.
(2006). Outbreak of Infection by Carbapenem-Resistant Acinetobacter baumannii Producing the Carbapenemase OXA-58 in Belgium. J. Clin. Microbiol.
44: 4189-4192
[Abstract]
[Full Text]
-
Coelho, J. M., Turton, J. F., Kaufmann, M. E., Glover, J., Woodford, N., Warner, M., Palepou, M.-F., Pike, R., Pitt, T. L., Patel, B. C., Livermore, D. M.
(2006). Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England.. J. Clin. Microbiol.
44: 3623-3627
[Abstract]
[Full Text]
-
Ying, C. M., Ling, T. K. W., Lee, C. C., Ling, J. M.
(2006). Characterization of carbapenem-resistant Acinetobacter baumannii in Shanghai and Hong Kong. J Med Microbiol
55: 799-802
[Full Text]
-
Jacoby, G. A.
(2006). {beta}-Lactamase Nomenclature.. Antimicrob. Agents Chemother.
50: 1123-1129
[Full Text]
-
Walther-Rasmussen, J., Hoiby, N.
(2006). OXA-type carbapenemases. J Antimicrob Chemother
57: 373-383
[Abstract]
[Full Text]
-
Coelho, J., Woodford, N., Afzal-Shah, M., Livermore, D.
(2006). Occurrence of OXA-58-Like Carbapenemases in Acinetobacter spp. Collected over 10 Years in Three Continents. Antimicrob. Agents Chemother.
50: 756-758
[Abstract]
[Full Text]
-
Brown, S., Amyes, S.
(2006). OXA {beta}-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother
57: 1-3
[Abstract]
[Full Text]
-
Heritier, C., Poirel, L., Fournier, P.-E., Claverie, J.-M., Raoult, D., Nordmann, P.
(2005). Characterization of the Naturally Occurring Oxacillinase of Acinetobacter baumannii. Antimicrob. Agents Chemother.
49: 4174-4179
[Abstract]
[Full Text]
-
Naas, T., Levy, M., Hirschauer, C., Marchandin, H., Nordmann, P.
(2005). Outbreak of Carbapenem-Resistant Acinetobacter baumannii Producing the Carbapenemase OXA-23 in a Tertiary Care Hospital of Papeete, French Polynesia. J. Clin. Microbiol.
43: 4826-4829
[Abstract]
[Full Text]
-
Marque, S., Poirel, L., Heritier, C., Brisse, S., Blasco, M. D., Filip, R., Coman, G., Naas, T., Nordmann, P.
(2005). Regional Occurrence of Plasmid-Mediated Carbapenem-Hydrolyzing Oxacillinase OXA-58 in Acinetobacter spp. in Europe. J. Clin. Microbiol.
43: 4885-4888
[Abstract]
[Full Text]
-
Heritier, C., Poirel, L., Lambert, T., Nordmann, P.
(2005). Contribution of Acquired Carbapenem-Hydrolyzing Oxacillinases to Carbapenem Resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother.
49: 3198-3202
[Abstract]
[Full Text]
-
Jeon, B.-C., Jeong, S. H., Bae, I. K., Kwon, S. B., Lee, K., Young, D., Lee, J. H., Song, J. S., Lee, S. H.
(2005). Investigation of a Nosocomial Outbreak of Imipenem-Resistant Acinetobacter baumannii Producing the OXA-23 {beta}-Lactamase in Korea. J. Clin. Microbiol.
43: 2241-2245
[Abstract]
[Full Text]
-
Poirel, L., Marque, S., Heritier, C., Segonds, C., Chabanon, G., Nordmann, P.
(2005). OXA-58, a Novel Class D {beta}-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother.
49: 202-208
[Abstract]
[Full Text]
-
Girlich, D., Naas, T., Nordmann, P.
(2004). OXA-60, a Chromosomal, Inducible, and Imipenem-Hydrolyzing Class D {beta}-Lactamase from Ralstonia pickettii. Antimicrob. Agents Chemother.
48: 4217-4225
[Abstract]
[Full Text]
-
Nagano, N., Nagano, Y., Cordevant, C., Shibata, N., Arakawa, Y.
(2004). Nosocomial Transmission of CTX-M-2 {beta}-Lactamase-Producing Acinetobacter baumannii in a Neurosurgery Ward. J. Clin. Microbiol.
42: 3978-3984
[Abstract]
[Full Text]
-
Da Silva, G. J., Quinteira, S., Bertolo, E., Sousa, J. C., Gallego, L., Duarte, A., Peixe, L., on behalf of the Portuguese Resistance Study Group,
(2004). Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula. J Antimicrob Chemother
54: 255-258
[Abstract]
[Full Text]
-
Yu, Y.-S., Yang, Q., Xu, X.-W., Kong, H.-S., Xu, G.-Y., Zhong, B.-Y.
(2004). Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital. J Med Microbiol
53: 653-656
[Abstract]
[Full Text]
-
Girlich, D., Naas, T., Nordmann, P.
(2004). Biochemical Characterization of the Naturally Occurring Oxacillinase OXA-50 of Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
48: 2043-2048
[Abstract]
[Full Text]
-
Heritier, C., Poirel, L., Nordmann, P.
(2004). Genetic and Biochemical Characterization of a Chromosome-Encoded Carbapenem-Hydrolyzing Ambler Class D {beta}-Lactamase from Shewanella algae. Antimicrob. Agents Chemother.
48: 1670-1675
[Abstract]
[Full Text]
-
Poirel, L., Heritier, C., Tolun, V., Nordmann, P.
(2004). Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother.
48: 15-22
[Abstract]
[Full Text]
-
Poirel, L., Heritier, C., Nordmann, P.
(2004). Chromosome-Encoded Ambler Class D {beta}-Lactamase of Shewanella oneidensis as a Progenitor of Carbapenem-Hydrolyzing Oxacillinase. Antimicrob. Agents Chemother.
48: 348-351
[Abstract]
[Full Text]
-
Corvec, S., Caroff, N., Espaze, E., Giraudeau, C., Drugeon, H., Reynaud, A.
(2003). AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. J Antimicrob Chemother
52: 629-635
[Abstract]
[Full Text]
-
Dalla-Costa, L. M., Coelho, J. M., Souza, H. A. P. H. M., Castro, M. E. S., Stier, C. J. N., Bragagnolo, K. L., Rea-Neto, A., Penteado-Filho, S. R., Livermore, D. M., Woodford, N.
(2003). Outbreak of Carbapenem-Resistant Acinetobacter baumannii Producing the OXA-23 Enzyme in Curitiba, Brazil. J. Clin. Microbiol.
41: 3403-3406
[Abstract]
[Full Text]
-
Fernandez-Cuenca, F., Martinez-Martinez, L., Conejo, M{a} C., Ayala, J. A., Perea, E. J., Pascual, A.
(2003). Relationship between {beta}-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother
51: 565-574
[Abstract]
[Full Text]
-
Heritier, C., Poirel, L., Aubert, D., Nordmann, P.
(2003). Genetic and Functional Analysis of the Chromosome-Encoded Carbapenem-Hydrolyzing Oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob. Agents Chemother.
47: 268-273
[Abstract]
[Full Text]
-
Lopez-Otsoa, F., Gallego, L., Towner, K. J., Tysall, L., Woodford, N., Livermore, D. M.
(2002). Endemic Carbapenem Resistance Associated with OXA-40 Carbapenemase among Acinetobacter baumannii Isolates from a Hospital in Northern Spain. J. Clin. Microbiol.
40: 4741-4743
[Abstract]
[Full Text]
-
Bou, G., Cartelle, M., Tomas, M., Canle, D., Molina, F., Moure, R., Eiros, J. M., Guerrero, A.
(2002). Identification and Broad Dissemination of the CTX-M-14 {beta}-Lactamase in Different Escherichia coli Strains in the Northwest Area of Spain. J. Clin. Microbiol.
40: 4030-4036
[Abstract]
[Full Text]
-
Niumsup, P., Wuthiekanun, V.
(2002). Cloning of the class D {beta}-lactamase gene from Burkholderia pseudomallei and studies on its expression in ceftazidime-susceptible and -resistant strains. J Antimicrob Chemother
50: 445-455
[Abstract]
[Full Text]
-
Bonnet, R., Marchandin, H., Chanal, C., Sirot, D., Labia, R., De Champs, C., Jumas-Bilak, E., Sirot, J.
(2002). Chromosome-Encoded Class D {beta}-Lactamase OXA-23 in Proteus mirabilis. Antimicrob. Agents Chemother.
46: 2004-2006
[Abstract]
[Full Text]
-
Poirel, L., Gerome, P., De Champs, C., Stephanazzi, J., Naas, T., Nordmann, P.
(2002). Integron-Located oxa-32 Gene Cassette Encoding an Extended-Spectrum Variant of OXA-2 {beta}-Lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
46: 566-569
[Abstract]
[Full Text]
-
Franceschini, N., Boschi, L., Pollini, S., Herman, R., Perilli, M., Galleni, M., Frere, J.-M., Amicosante, G., Rossolini, G. M.
(2001). Characterization of OXA-29 from Legionella (Fluoribacter) gormanii: Molecular Class D beta -Lactamase with Unusual Properties. Antimicrob. Agents Chemother.
45: 3509-3516
[Abstract]
[Full Text]
-
Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., Warnock, D. W.
(2001). Antifungal Susceptibility Testing: Practical Aspects and Current Challenges. Clin. Microbiol. Rev.
14: 643-658
[Abstract]
[Full Text]
-
Livermore, D. M., Oakton, K. J., Carter, M. W., Warner, M.
(2001). Activity of Ertapenem (MK-0826) versus Enterobacteriaceae with Potent {beta}-Lactamases. Antimicrob. Agents Chemother.
45: 2831-2837
[Abstract]
[Full Text]
-
Salama, S. M., Atwal, H., Gandhi, A., Simon, J., Poglod, M., Montaseri, H., Khan, J. K., Furukawa, T., Saito, H., Nishida, K., Higashitani, F., Uji, T., Unemi, N., Daneshtalab, M., Micetich, R. G.
(2001). In Vitro and In Vivo Activities of Syn2836, Syn2869, Syn2903, and Syn2921: New Series of Triazole Antifungal Agents. Antimicrob. Agents Chemother.
45: 2420-2426
[Abstract]
[Full Text]
-
Aubert, D., Poirel, L., Chevalier, J., Leotard, S., Pages, J.-M., Nordmann, P.
(2001). Oxacillinase-Mediated Resistance to Cefepime and Susceptibility to Ceftazidime in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
45: 1615-1620
[Abstract]
[Full Text]
-
Chu, Y.-W., Afzal-Shah, M., Houang, E. T. S., Palepou, M.-F. I., Lyon, D. J., Woodford, N., Livermore, D. M.
(2001). IMP-4, a Novel Metallo-{beta}-Lactamase from Nosocomial Acinetobacter spp. Collected in Hong Kong between 1994 and 1998. Antimicrob. Agents Chemother.
45: 710-714
[Abstract]
[Full Text]
-
Poirel, L., Girlich, D., Naas, T., Nordmann, P.
(2001). OXA-28, an Extended-Spectrum Variant of OXA-10 {beta}-Lactamase from Pseudomonas aeruginosa and Its Plasmid- and Integron-Located Gene. Antimicrob. Agents Chemother.
45: 447-453
[Abstract]
[Full Text]
-
Afzal-Shah, M., Woodford, N., Livermore, D. M.
(2001). Characterization of OXA-25, OXA-26, and OXA-27, Molecular Class D {beta}-Lactamases Associated with Carbapenem Resistance in Clinical Isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother.
45: 583-588
[Abstract]
[Full Text]
-
Queenan, A. M., Torres-Viera, C., Gold, H. S., Carmeli, Y., Eliopoulos, G. M., Moellering, R. C. Jr., Quinn, J. P., Hindler, J., Medeiros, A. A., Bush, K.
(2000). SME-Type Carbapenem-Hydrolyzing Class A beta -Lactamases from Geographically Diverse Serratia marcescens Strains. Antimicrob. Agents Chemother.
44: 3035-3039
[Abstract]
[Full Text]
-
Bou, G., Cerveró, G., Domínguez, M. A., Quereda, C., Martínez-Beltrán, J.
(2000). Characterization of a Nosocomial Outbreak Caused by a Multiresistant Acinetobacter baumannii Strain with a Carbapenem-Hydrolyzing Enzyme: High-Level Carbapenem Resistance in A. baumannii Is Not Due Solely to the Presence of beta -Lactamases. J. Clin. Microbiol.
38: 3299-3305
[Abstract]
[Full Text]
-
Bou, G., Oliver, A., Martínez-Beltrán, J.
(2000). OXA-24, a Novel Class D beta -Lactamase with Carbapenemase Activity in an Acinetobacter baumannii Clinical Strain. Antimicrob. Agents Chemother.
44: 1556-1561
[Abstract]
[Full Text]
-
Helmerhorst, E. J., Reijnders, I. M., van 't Hof, W., Simoons-Smit, I., Veerman, E. C. I., Amerongen, A. V. N.
(1999). Amphotericin B- and Fluconazole-Resistant Candida spp., Aspergillus fumigatus, and Other Newly Emerging Pathogenic Fungi Are Susceptible to Basic Antifungal Peptides. Antimicrob. Agents Chemother.
43: 702-704
[Abstract]
[Full Text]
-
Sheehan, D. J., Hitchcock, C. A., Sibley, C. M.
(1999). Current and Emerging Azole Antifungal Agents. Clin. Microbiol. Rev.
12: 40-79
[Abstract]
[Full Text]